Who Paid My Doc
Michael Verdolin
Interventional Pain Medicine La Mesa, CA Medical Doctor
NPI 1477525657 CMS profile 112318
7051 Alvarado Rd, Suite 101, La Mesa, CA 91942
General payments
$506,682
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$56,171
Through program year 2025, Michael Verdolin of La Mesa, CA is reported in the CMS Open Payments database as having received $506,682 across 1,167 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $56,171 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $3,789 | 62 | |
| 2024 | General | $7,106 | 77 | |
| 2023 | General | $87,994 | 174 | |
| 2022 | General | $45,649 | 204 | |
| 2021 | General | $77,757 | 213 | |
| 2020 | General | $135,661 | 215 | |
| 2019 | General | $148,725 | 222 |
Beside peers
- Michael Verdolin
- Interventional Pain Medicine median
- Middle half of Interventional Pain Medicine
- National median
In program year 2025, general payments to Michael Verdolin were reported at $3,789. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.
Show as a table
| Year | Michael Verdolin | Interventional Pain Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $148,725 | $684 | $216–$2,079 | $163 |
| 2020 | $135,661 | $382 | $122–$1,109 | $114 |
| 2021 | $77,757 | $552 | $167–$1,554 | $132 |
| 2022 | $45,649 | $605 | $187–$1,924 | $149 |
| 2023 | $87,994 | $671 | $195–$1,915 | $160 |
| 2024 | $7,106 | $684 | $206–$1,837 | $164 |
| 2025 | $3,789 | $657 | $184–$1,753 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 54 billing codesPaid by Medicare
$165,882
Medicare patients
145
Services billed
12,410
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 39% | |
| Depression | 32% | |
| Ischemic heart disease | 30% | |
| Chronic kidney disease | 30% | |
| Osteoporosis | 26% | |
| COPD | 23% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 | Office | 80 | 564 | $3,077 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Q9966 | Office | 88 | 10,100 | $2,939 |
| Infusion, normal saline solution, 250 cc J7050 | Office | 90 | 322 | $166 |
| Injection, fentanyl citrate, 0.1 mg J3010 | Office | 29 | 41 | $30 |
| Injection, dexamethasone sodium phosphate, 1 mg J1100 | Office | 19 | 230 | $21 |
| Injection, midazolam hydrochloride, per 1 mg J2250 | Office | 36 | 112 | $12 |
| Injection, ketorolac tromethamine, per 15 mg J1885 | Office | 15 | 23 | $12 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1,167 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Interventional Pain Medicine in California
Tim Leier
Interventional Pain Medicine · Rancho Mirage, CA
Jonathan Grossman
Interventional Pain Medicine · Visalia, CA
Kasra Maasumi
Interventional Pain Medicine · Rancho Santa Margarita, CA
Andrew Germanovich
Interventional Pain Medicine · Rancho Mirage, CA
David Lee
Interventional Pain Medicine · Yorba Linda, CA
Standiford Helm
Interventional Pain Medicine · Orange, CA
Related records
Interventional Pain Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Interventional Pain Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.